1. Breaking down barriers: The potential of smarter CAR‐engineered NK cells against solid tumors
   Muhammad B. Khawar et al, 2023, Journal of Cellular Biochemistry CrossRef
2. Novel C-type lectin mediated non-specific cytotoxic cells killing activity through NCCRP-1 in nile tilapia (Oreochromis niloticus)
   Yu Huang et al, 2024, Fish & Shellfish Immunology CrossRef
3. CAR-T cell therapy in India requires a paradigm shift in training, education and health care processes
   Akshay Ravindranath et al, 2022, Cytotherapy CrossRef
4. Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
   Barbara Seliger et al, 2022, Frontiers in Immunology CrossRef
5. Transferrin Mediated NCC Killing Activity through NCCRP-1 in Nile Tilapia (Oreochromis niloticus)
   Yu Huang et al, 2022, Fishes CrossRef
6. Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells
   Chutipa Chiawpanit et al, 2024, International Immunopharmacology CrossRef
7. Colorectal Cancer Stages, Progress, Genetic Predisposition, and Immune Surveillance
   Samaa Abdullah, 2022, Recent Understanding of Colorectal Cancer Treatment CrossRef
8. Co-inhibition of adenosine 2b receptor and programmed death-ligand 1 promotes the recruitment and cytotoxicity of natural killer cells in oral squamous cell carcinoma
   Bing Wang et al, 2023, PeerJ CrossRef
9. Challenges of chimeric antigen receptor-T/natural killer cell therapy in the treatment of solid tumors: focus on colorectal cancer and evaluation of combination therapies
   Haifeng Wang et al, 2023, Molecular and Cellular Biochemistry CrossRef